A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD)
Clinical trial NCT04849741 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04849741
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2025-08-22
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.